Editorial Board

Editors in Chief

  • Jeannette Lechner-Scott, PhD, John Hunter Hospital, Department of Neurology, Newcastle, 2305, Australia
  • Michael Levy, MD, PhD, Massachusetts General Hospital, Department of Neurology, 55 Fruit Street Boston, 02114-2621, Boston, Massachusetts, United States of America
  • Ann Yeh, MD, The Hospital for Sick Children, Toronto, M5G 1X8, Ontario, Canada

Executive Editors

  • Gavin Giovannoni, MBBCh, PhD, Barts and the London School of Medicine and Dentistry Centre for Neuroscience and Trauma, 4 Newark Street, E1 2AT, London, United Kingdom
  • Christopher Hawkes, Queen Mary University of London Barts and The London School of Medicine and Dentistry, Garrod Building, Turner Street, Whitechapel, E1 2AD, London, United Kingdom

Associate Editors

  • Karim L. Kreft, MD, PhD, Erasmus Medical Center, Department of Neurology, Rotterdam, Netherlands
  • Maria A. Rocca, MD, Vita-Salute San Raffaele University, Unit of Neurology and Neuroimaging of CNS White Matter Unit, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
  • Steve Simpson-Yap, The University of Melbourne School of Population and Global Health, Melbourne, Australia

Section Editors

Neuro-ophthalmology

  • Laura Balcer, MD, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
  • Robert Sergott, MD, Wills Eye Hospital, Philadelphia, Pennsylvania, United States of America

Infection

  • Joseph Berger, MD, FACP, FAAN, FANA, University of Pennsylvania, Department of Neurology, Philadelphia, Pennsylvania, United States of America
  • Julian Gold, MD, PhD, University of Sydney, The Albion Centre, NSW 2010, Australia

Neuroethics

  • James Bernat, MD, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States of America

Pediatric MS

  • Russell Dale, MRCP PhD, The University of Sydney, Sydney, New South Wales, Australia

Epidemiology

  • Melinda Magyari, MD, PhD, Copenhagen University Hospital Danish Multiple Sclerosis Research Center, Glostrup, Denmark

Measurement / quality of life

  • Markus D'Souza, MD, University Hospital Basel,, Department of Neurology, , Switzerland
  • Jeremy C. Hobart, PhD, Plymouth University Peninsula School of Medicine, Plymouth, United Kingdom

Teaching

  • Mark Keegan, MD, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States of America
  • Andrew J. Solomon, MD, University of Vermont, Department of Neurological Sciences, Burlington, Vermont, United States of America

Rehabilitation

  • Alon Kalron, PhD, PT, Tel Aviv University Sackler, Faculty of Medicine, Tel Aviv, Israel
  • Jürg Kesselring, University of Zurich, Zurich, Switzerland

Clinical Neurology

  • Mark Freedman, MSc, MD, University of Ottawa, Ottawa, Ontario, Canada
  • Hans-Peter Hartung, MD, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
  • Jun-Ichi Kira, MD, PhD, Kyushu University, School of Medicine, Graduate School of Medical Sciences,, Faculty of Medical Sciences, Neurological Institute,, Department of Neurology, Fukuoka, Japan
  • Mark Slee, BAppSc, BMBS, FRACP, PhD, Flinders University College of Medicine and Public Health, Adelaide, Australia

Immunology

  • Rune Hoglund, MD, PhD, Akershus University Hospital, Department of Neurology, Lørenskog, Norway
  • Joseph Sabatino, MD, PhD, University of California San Francisco, Department of Neurology, San Francisco, California, United States of America
  • Finn Sellebjerg, MD, PhD, DMSci, Copenhagen University Hospital, København, Denmark

Psychology and Fatigue

  • Dawn Langdon, PhD, FBPS, Royal Holloway University of London, Egham, United Kingdom
  • Lisa A. S. Walker, PhD, Ottawa Hospital, Ottawa, Ontario, Canada

Imaging

  • Saadallah Ramadan, PhD, The University of Newcastle, Callaghan, New South Wales, Australia

Cerebrospinal Fluid

  • Edward John Thompson, MD, PhD, DSc, The National Hospital,, Department of Neuroimmunology, London, United Kingdom

Experimental Models

  • Sandra Amor, PhD, Amsterdam UMC Location VUmc, Department of Pathology, Amsterdam, Netherlands

Lay Summaries

  • Paulette Smokovich, PhD, Children's Hospital Los Angeles, Los Angeles, California, United States of America

Statistics

  • Gary Cutter, PhD, Birmingham, Alabama, United States of America
  • Ben Jacobs, BM BCh, Queen Mary University of London, London, United Kingdom
  • Maria Pia Sormani, University of Genoa, Department of Health Sciences, Genoa, Italy

Pathology

  • Ranjan Dutta, PhD, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio, United States of America
  • Margaret Esiri, DM (Oxon), FRCPath, John Radcliffe Hospital Neurology Department, Oxford, United Kingdom
  • Carlos A. Pardo, MD, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

Reviews

  • Patricia Coyle, Stony Brook University, Stony Brook, New York, United States of America

Biomarkers

  • Paul Friedemann, MD

Stem Cell Research

  • Paolo Muraro
  • Stefano Pluchino, MD, PhD

Therapy

  • Lilyana Amezcua, MD, MS, University of Southern California, Los Angeles, California, United States of America
  • Barbara Giesser, MD, Pacific Neuroscience Institute, Santa Monica, California, United States of America

Social Media Editor

  • Jonathan Santoro, MD, Children’s Hospital Los Angeles, Los Angeles, California, United States of America

Former Co Editor-in-Chief

  • Brenda Banwell, The Children's Hospital of Philadelphia Division of Neurology
  • Fred Lublin, Icahn School of Medicine at Mount Sinai Estelle and Daniel Maggin, Department of Neurology
  • Emmanuelle L. Waubant, University of California San Francisco, Department of Neurology

Editorial Board

  • Brenda Banwell, MD, The Children's Hospital of Philadelphia Division of Neurology, Philadelphia, Pennsylvania, United States of America
  • Pavan Bhargava, MD, Johns Hopkins Medicine, Department of Neurology and Neurosurgery, Baltimore, Maryland, United States of America
  • Alexey Boiko, PhD, MD, Pirogov Russian National Research Medical University, Moskva, Russian Federation
  • Jodie M. Burton, MD, MSc, FRCPC, University of Calgary, Department of Clinical Neurosciences, Calgary, Alberta, Canada
  • Helmut Butzkueven, The Royal Melbourne Hospital, Parkville, Australia
  • Jorge Correale, Foundation for the Fight against Childhood Neurological Diseases, Buenos Aires, Argentina
  • Fernando Hamuy Diaz de Bedoya, PhD,MD, Latinoamerican Committe for Treatment and Research in Multiple Sclerosis,
  • Oscar Fernandez, Regional University Hospital of Malaga, Malaga, Spain
  • Kazuo Fujihara, MD, Tohoku University Graduate School of Medicine, Department of Neurology, Sendai, Japan
  • Gloria von Geldern, MD, University of Washington, Department of Neurology, Seattle, Washington, United States of America
  • Eva Havrdova, Charles University, Praha, Czechia
  • Stanley Hawkins, MD, FRCP, Queen's University Belfast, Belfast, United Kingdom
  • Ludwig Kappos, University Hospital Basel, Basel, Switzerland
  • Jens Kuhle, MD, PhD, University Hospital Basel, Basel, Switzerland
  • Claudia Lucchinetti, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States of America
  • Amir Hadi Maghzi, MD, Biogen Inc, Cambridge, Massachusetts, United States of America
  • Bardia Nourbakhsh, MD, MAS, Johns Hopkins Medicine, Department of Neurology and Neurosurgery, Baltimore, Maryland, United States of America
  • Mohammed Ali Sahraian, Tehran University of Medical Sciences, Multiple Sclerosis Research Center, Tehran, Iran
  • Afsaneh Shirani, MD, MSCI, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
  • Sigga Sveinbjornsdottir, National University Hospital of Iceland, Reykjavík, Iceland
  • Jaime Toro, Santa Fe of Bogota Foundation, Bogotá, Colombia
  • Adi Vaknin-Dembinsky, MD, PhD, Hadassah University Hospital - Ein Kerem, Neurology Department, Jerusalem, Israel
  • Ernie Willoughby, Auckland City Hospital, Auckland, New Zealand
  • Bassem Yamout, American University of Beirut, Beirut, Lebanon
  • Magd Zakaria, Ain Shams University, Cairo, Egypt